Cambridge University and GSK sign immunology R&D collaboration

By Yahoo! Finance | Oct 22, 2024 at 04:44 AM EST

GSK invests £50m in a partnership with Cambridge University to accelerate immune-related disease research. The collaboration aims to improve current treatments and develop new ones for respiratory and kidney diseases by leveraging AI and patient data.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.